Abstract:TLR8-mediated NF-kappaB and IRF7 activation are abolished in human IRAK-deficient 293 cells and IRAK4-deficient fibroblast cells. Both wild-type and kinase-inactive mutants of IRAK and IRAK4, respectively, restored TLR8-mediated NF-kappaB and IRF7 activation in the IRAK- and IRAK4-deficient cells, indicating that the kinase activity of IRAK and IRAK4 is probably redundant for TLR8-mediated signaling. We recently found that TLR8 mediates a unique NF-kappaB activation pathway in human 293 cells and mouse embryonic fibroblasts, accompanied only by IkappaBalpha phosphorylation and not IkappaBalpha degradation, whereas interleukin (IL)-1 stimulation causes both IkappaBalpha phosphorylation and degradation. The intermediate signaling events mediated by IL-1 (including IRAK modifications and degradation and TAK1 activation) were not detected in cells stimulated by TLR8 ligands. TLR8 ligands trigger similar levels of IkappaBalpha phosphorylation and NF-kappaB and JNK activation in TAK1(-/-) mouse embryo fibroblasts (MEFs) as compared with wild-type MEFs, whereas lack of TAK1 results in reduced IL-1-mediated NF-kappaB activation and abolished IL-1-induced JNK activation. The above results indicate that although TLR8-mediated NF-kappaB and JNK activation are IRAK-dependent, they do not require IRAK modification and are TAK1-independent. On the other hand, TLR8-mediated IkappaBalpha phosphorylation, NF-kappaB, and JNK activation are completely abolished in MEKK3(-/-) MEFs, whereas IL-1-mediated signaling was only moderately reduced in these deficient MEFs as compared with wild-type cells. The differences between IL-1R- and TLR8-mediated NF-kappaB activation are also reflected at the level of IkappaB kinase (IKK) complex. TLR8 ligands induced IKKgamma phosphorylation, whereas IKKalpha/beta phosphorylation and IKKgamma ubiquitination that can be induced by IL-1 were not detected in cells treated with TLR8 ligands. We postulate that TLR8-mediated MEKK3-dependent IKKgamma phosphorylation might play an important role in the activation of IKK complex, leading to IkappaBalpha phosphorylation.

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent

The research advance of IRAK1 in immune regulation

The IRAK-1-BCL10-MALT1-TRAF6-TAK1 Cascade Mediates Signaling to NF-κB from Toll-like Receptor 4

The IRAK-M death domain: a tale of three surfaces

Interleukin-1 (Il-1)-induced TAK1-dependent Versus MEKK3-dependent NFκB Activation Pathways Bifurcate at IL-1 Receptor-associated Kinase Modification

IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB

Β-Trcp-mediated IRAK1 Degradation Releases TAK1-TRAF6 from the Membrane to the Cytosol for TAK1-Dependent NF-κB Activation

Poly(I-C)-induced Toll-like Receptor 3 (Tlr3)-Mediated Activation of NFκB and MAP Kinase is Through an Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR

Modulation of Toll–interleukin 1 receptor mediated signaling

IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol

Differential Regulation of Interleukin 1 Receptor and Toll-like Receptor Signaling by MEKK3

Selective IRAK4 degradation, not kinase inhibition, blocks TLR-activated NF-Kb and p38 Signaling leading to broad cytokine inhibition

IRAK2 Directs Stimulus-Dependent Nuclear Export of Inflammatory Mrnas.

Il-1-Induced Nf Kappa B and C-Jun N-Terminal Kinase (jnk) Activation Diverge at Il-1 Receptor-Associated Kinase (Irak)

Poly(Di Center Dot Dc)-Induced Toll-Like Receptor 3 (Tlr3)-Mediated Activation Of Nf Kappa B And Map Kinase Is Through An Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing The Signaling Components Tlr3-Traf6-Tak1-Tab2-Pkr

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase